Tag: cognitive enhancement
Browse all articles tagged with “cognitive enhancement”.
6 articles
Nootropic Peptides: The Research Behind Cognitive Enhancement Compounds
A comprehensive review of nootropic peptide research including Selank, Semax, Dihexa, P21, PE-22-28, Pinealon, and Cortagen — covering mechanisms of action, evidence quality, and current research stages.
Dihexa (PNB-0408): The Ultra-Potent Nootropic Peptide in Cognitive Research
A comprehensive research overview of Dihexa (PNB-0408), the angiotensin IV analog reported to be seven orders of magnitude more potent than BDNF at promoting synaptogenesis. Explore its HGF/c-Met mechanism, animal cognition data, and current research status.
What Is Selank? A Research Overview
Selank is a synthetic heptapeptide derived from tuftsin, developed in Russia as an anxiolytic and nootropic compound that modulates neurotransmitter systems and immune function.
P21 (P021): The CNTF-Derived Peptide Driving Neurogenesis Research
An in-depth exploration of P21 (P021), a small peptide derived from ciliary neurotrophic factor (CNTF) that crosses the blood-brain barrier and promotes neurogenesis through BDNF upregulation. Review its Alzheimer's research data and therapeutic potential.
What Is Semax? A Research Overview
Semax is a synthetic heptapeptide derived from ACTH(4-7), developed in Russia as a nootropic and neuroprotective agent that enhances cognitive function and promotes neuronal survival.
PE-22-28: The PACAP-Derived Neuroprotective Peptide in Early Research
A research overview of PE-22-28, a novel heptapeptide derived from pituitary adenylate cyclase-activating polypeptide (PACAP) that selectively targets the PAC1 receptor for neuroprotection and cognitive enhancement.
For informational purposes only. Not medical advice. Always consult with qualified healthcare professionals.